| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | DE19548476A1 Zielgerichtete Verbindungen mit knorpel- und/oder knocheninduzierender Aktivität Targeted compounds with cartilage and / or osteoinductive activity |
| 06/26/1997 | DE19548222A1 Verfahren zur mikrobiellen Herstellung von Aminosäuren durch gesteigerte Aktivität von Exportcarriern Process for the microbial production of amino acids by increased activity of export carriers |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | DE19547933A1 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung Multimeric forms of IL-16, process for their preparation and use |
| 06/26/1997 | DE19547733A1 Nucleic acid encoding enzyme involved in starch synthesis and modification |
| 06/26/1997 | DE19547324A1 cDNA encoding human mucin 8 |
| 06/26/1997 | CA2242402A1 Grapevine leafroll virus proteins and their uses |
| 06/26/1997 | CA2241371A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | CA2241040A1 Improved pharmaceutical compositions |
| 06/26/1997 | CA2240938A1 Utrophin gene expression |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/26/1997 | CA2238995A1 Methods for identifying compounds that bind to a target |
| 06/25/1997 | EP0780687A2 Process for preparation of a synthetic calibrator for sandwich immunoassays |
| 06/25/1997 | EP0780475A1 CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
| 06/25/1997 | EP0780472A2 Stress proteins |
| 06/25/1997 | EP0780398A2 Process for purifying tammhorsfall glycoprotein or uromodulin, their purified products and method for making the discrimination between both of them |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 06/25/1997 | EP0779927A1 A method of improved production of insulin-like growth factor |
| 06/25/1997 | EP0779925A2 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe |
| 06/25/1997 | EP0779924A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0779896A1 New process for the production of biologically active protein |
| 06/25/1997 | EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
| 06/25/1997 | EP0779815A1 Surface-modifying copolymers having cell adhesion properties |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | EP0641358A4 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR. |
| 06/25/1997 | EP0623145B1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications |
| 06/25/1997 | EP0527212B1 Analyte determination in biological fluids in the presence of interfering substances |
| 06/25/1997 | CN1152942A N-terminally extended proteins expressed in yeast |
| 06/25/1997 | CN1152941A Genes for the synthesis of antipathogenic substances |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152938A Growth control for cells encapsulated within bioartificial organs |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152935A Papillomavirus vaccines |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |
| 06/25/1997 | CN1152924A Proteins from mammaliam liver and their use in oncology |
| 06/25/1997 | CN1152923A Hydrophilic metal complexes |
| 06/25/1997 | CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
| 06/25/1997 | CN1152579A Method of preparing cyclic vasoactive peptides |
| 06/25/1997 | CN1035257C Midified plutelet factor-4 |
| 06/25/1997 | CN1035256C Process for preparation of new polypetide compound |
| 06/24/1997 | US5641876 Rice actin gene and promoter |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641874 DNA encoding bactericidal/permeability increasing proteins |
| 06/24/1997 | US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis |
| 06/24/1997 | US5641868 Interlekin-6 compositions, and a production process thereof |
| 06/24/1997 | US5641867 Antitumor agents |
| 06/24/1997 | US5641866 Bcl-2-associated proteins |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641861 μopioid receptor ligands: agonists and antagonists |
| 06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
| 06/24/1997 | US5641837 Method of detecting collagen degradation in vivo |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/24/1997 | US5641751 Polypeptides that bind to tumor necrosis factor-alpha, preventing it from binding to its receptors |
| 06/24/1997 | US5641750 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/24/1997 | US5641748 Cd2 associated intracellular proteins |
| 06/24/1997 | US5641744 Treatment of diabetes mellitus |
| 06/24/1997 | US5641743 Therapeutic compositions and methods for use of heparin-binding brain mitogens |
| 06/24/1997 | US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation |
| 06/24/1997 | US5641680 For gene therapy treatment |
| 06/24/1997 | US5641676 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 06/24/1997 | US5641675 Inhibiting intracellular localization of target mrna molecule to periphery of cell in vitro by introducing antisense nucleotide complementary to zipcode region of molecule |
| 06/24/1997 | US5641674 Nucleotide sequences and proteins conferring cycloheximide resistance |
| 06/24/1997 | US5641672 Nucleic acid molecule; vectors; plasmids; host vector system |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641666 Soraphen A resistant fungi and acetyl-CoA carboxylase |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641663 Regulatory polynucleotide comprising linked promoter and signal polynucleotides operatively linked to polynucleotide encoding eukaryotic protein |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641656 Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them |
| 06/24/1997 | US5641655 Genetic engineered dna encoding a protein fusion |
| 06/24/1997 | US5641654 Medical diagnosis; accuracy |
| 06/24/1997 | US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia |
| 06/24/1997 | US5641652 Insect retinoid-like receptor compositions and methods |
| 06/24/1997 | US5641651 Synthetic herpes simplex virus promoters |
| 06/24/1997 | US5641650 Expression of heterologous polypeptides in halobacteria |
| 06/24/1997 | US5641649 Expression of osteogenic factor OP-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 06/24/1997 | US5641648 Dna sequences coding for the expression of the large polypeptides; genetic engineering |
| 06/24/1997 | US5641647 Serum free medium |
| 06/24/1997 | US5641646 Purification of fused protein and human glicentin is carried out by utilizing a reversible covalent bond of a cysteine residue with the stationary phase of a chromatography column |
| 06/24/1997 | US5641638 Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof |
| 06/24/1997 | US5641629 Spectroscopically detectable nucleic acid ligands |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
| 06/24/1997 | US5641490 Recombinant avipox virus comprising exogenous dna from infectious bursal disease virus inserted into nonessential region of avipox virus genome, which expresses structural protein coded for by said exogenous dna |
| 06/24/1997 | US5641487 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 06/24/1997 | US5641486 Administering an anticancer agent or viricides to disassociate the binding |
| 06/24/1997 | US5641485 Caledothricins used in the treatment mycotic diseases |
| 06/24/1997 | US5641484 Introducing to tumor either vector comprising nucleic acid encoding simian virus antigen gene product linked to promoter or liposome complexed to said nucleic acid, wherein production of gene product suppresses tumor growth |
| 06/24/1997 | US5641483 Healing of cutaneous wounds, leg ulcers |
| 06/24/1997 | US5641474 Prevention of autoimmune diseases by aerosol administration of autoantigens |